Medifast Inc banner

Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 11.05 USD 1.19% Market Closed
Market Cap: $121.4m

EV/EBITDA

-1586.8
Current
148 849%
Cheaper
vs 3-y average of 1.1

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-1586.8
=
Enterprise Value
$-52.6m
/
EBITDA
$29k

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-1586.8
=
Enterprise Value
$-52.6m
/
EBITDA
$29k

Valuation Scenarios

Medifast Inc is trading above its 3-year average

If EV/EBITDA returns to its 3-Year Average (1.1), the stock would be worth $-0.01 (100% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-101%
Maximum Upside
No Upside Scenarios
Average Downside
100%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple -1 586.8 $11.05
0%
3-Year Average 1.1 $-0.01
-100%
5-Year Average 4.2 $-0.03
-100%
Industry Average 9.3 $-0.06
-101%
Country Average 14.4 $-0.1
-101%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
$-52.6m
/
Jan 2026
$29k
=
-1586.8
Current
$-52.6m
/
Dec 2026
$-4.5m
=
11.6
Forward
$-52.6m
/
Dec 2027
$-13.3m
=
3.9
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
US
Medifast Inc
NYSE:MED
121.5m USD -1 586.8 -6.5
FR
L'Oreal SA
PAR:OR
184.2B EUR 17.1 30.1
UK
Unilever PLC
LSE:ULVR
92B GBP 11.3 11.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.4T INR 36.9 38.4
UK
HALEON PLC
LSE:HLN
31.4B GBP 13.2 18.8
US
Estee Lauder Companies Inc
NYSE:EL
27.4B USD 14.3 -154.1
DE
Beiersdorf AG
XETRA:BEI
16.4B EUR 8.3 17.6
JP
Kao Corp
TSE:4452
2.7T JPY 10 22.6
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 38.5 63.9
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD -6 373.4 -4 624.4
IN
Dabur India Ltd
NSE:DABUR
801.7B INR 32.4 44.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Medifast Inc
NYSE:MED
Average EV/EBITDA: 20.2
Negative Multiple: -1 586.8
N/A N/A
FR
L'Oreal SA
PAR:OR
17.1
7%
2.4
UK
Unilever PLC
LSE:ULVR
11.3
4%
2.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.9
7%
5.3
UK
HALEON PLC
LSE:HLN
13.2
7%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
14.3
16%
0.9
DE
Beiersdorf AG
XETRA:BEI
8.3
3%
2.8
JP
Kao Corp
TSE:4452
10
7%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
38.5
12%
3.2
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
32.4
10%
3.2
P/E Multiple
Earnings Growth PEG
US
Medifast Inc
NYSE:MED
Average P/E: 30.9
Negative Multiple: -6.5
N/A N/A
FR
L'Oreal SA
PAR:OR
30.1
13%
2.3
UK
Unilever PLC
LSE:ULVR
11.2
-6%
N/A
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
38.4
7%
5.5
UK
HALEON PLC
LSE:HLN
18.8
11%
1.7
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -154.1 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
17.6
6%
2.9
JP
Kao Corp
TSE:4452
22.6
10%
2.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
63.9
18%
3.6
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
44.4
11%
4

Market Distribution

Lower than 100% of companies in the United States of America
Percentile
0th
Based on 9 875 companies
0th percentile
-1 586.8
Low
0 — 10
Typical Range
10 — 21.5
High
21.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 10
Median 14.4
70th Percentile 21.5
Max 1 767 274.1

Medifast Inc
Glance View

Market Cap
121.4m USD
Industry
Consumer products

Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.

MED Intrinsic Value
14.66 USD
Undervaluation 25%
Intrinsic Value
Price $11.05
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett